These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13088230)

  • 1. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case of visceral leishmaniasis in adult treated with N-methylglucamine antimony].
    NAPOLITANO F
    G Med Mil; 1952; 102(6):521-7. PubMed ID: 13034080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Presse Med (1893); 1951 Nov; 59(71):1475-7. PubMed ID: 14891720
    [No Abstract]   [Full Text] [Related]  

  • 4. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 5. [N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
    BOIX BARRIOS J
    Rev Cubana Pediatr; 1952 Jul; 24(7):433-42. PubMed ID: 12994219
    [No Abstract]   [Full Text] [Related]  

  • 6. Agranulocytosis following antimony therapy in kala-azar.
    BRAHMACHARI PN; MAITI CR; KAR CC
    J Indian Med Assoc; 1955 Oct; 25(10):408-10. PubMed ID: 13278551
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 8. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955
    [No Abstract]   [Full Text] [Related]  

  • 9. [Syndromes of reduced susceptibility to antimony in visceral leishmaniasis in the child].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Rev Esp Pediatr; 1953; 9(49):41-53. PubMed ID: 13074963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 12. [Micromethod in determination of antimony in blood and urine in visceral leishmaniasis during solusurmin therapy].
    LAPIN LN
    Vopr Med Khim; 1956; 2(4):309-15. PubMed ID: 13392574
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secretion of antimony and stilbamidine in the treatment of visceral leishmaniasis in children].
    MIKHAILOV VG
    Farmakol Toksikol; 1959; 22(2):175-8. PubMed ID: 13653152
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment for kala-azar: methods and results at the Infants' Clinic in Marseille].
    GIRAUD P; BERNARD R; ORSINI A
    Sem Hop; 1956 Jul 10-14; 32(42-43/6):2431-4. PubMed ID: 13351757
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of leishmaniasis].
    ARDAILLOU R; NAJEAN Y
    Vie Med; 1955 Oct; 36(10):1119-25. PubMed ID: 13282199
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Kala-Azar dermal leishmaniasis; a report of two typical cases with special reference to result of intensive antimonial therapy.
    TZU-TA C; PANG-MU C; LEE-SHIH L
    Chin Med J; 1953; 71(5):334-42. PubMed ID: 13127100
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leishmaniasis mucocutaneous americana; our experience in its treatment with glucantime].
    CORNEJO A
    Prensa Med Argent; 1955 Jun; 42(22):1605-6. PubMed ID: 13254644
    [No Abstract]   [Full Text] [Related]  

  • 20. [American leishmaniasis in hospitals of Bogotá Colombia].
    LAVERDE A
    Bull Soc Pathol Exot Filiales; 1952; 45(1):78-86. PubMed ID: 14935764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.